Published in Experientia on May 15, 1978
Structural basis for the interaction of antibiotics with the peptidyl transferase centre in eubacteria. Nature (2001) 6.40
Development and characterization of an in vivo central venous catheter Candida albicans biofilm model. Infect Immun (2004) 3.21
Coronin involved in phagocytosis: dynamics of particle-induced relocalization visualized by a green fluorescent protein Tag. Cell (1995) 2.42
Lack of beta 1 integrin gene in embryonic stem cells affects morphology, adhesion, and migration but not integration into the inner cell mass of blastocysts. J Cell Biol (1995) 2.39
Dictyostelium mutants lacking the cytoskeletal protein coronin are defective in cytokinesis and cell motility. J Cell Biol (1993) 2.12
Chemoattractant-controlled accumulation of coronin at the leading edge of Dictyostelium cells monitored using a green fluorescent protein-coronin fusion protein. Curr Biol (1995) 1.95
Steady-state and dynamic properties of cardiac sodium-calcium exchange. Sodium-dependent inactivation. J Gen Physiol (1992) 1.92
Summary of FDA antibody-mediated rejection workshop. Am J Transplant (2011) 1.87
Fluid-phase uptake by macropinocytosis in Dictyostelium. J Cell Sci (1997) 1.86
Summary of the US FDA approval of belatacept. Am J Transplant (2012) 1.68
Robotic mitral valve repair: trapezoidal resection and prosthetic annuloplasty with the da vinci surgical system. J Thorac Cardiovasc Surg (2000) 1.55
Irreversible effects on visible light on the retina: role of vitamin A. Science (1971) 1.45
Activation-dependent changes in human platelet PECAM-1: phosphorylation, cytoskeletal association, and surface membrane redistribution. J Cell Biol (1992) 1.34
The role of the cortical cytoskeleton: F-actin crosslinking proteins protect against osmotic stress, ensure cell size, cell shape and motility, and contribute to phagocytosis and development. J Cell Sci (1996) 1.32
Antibodies as antigens. The use of mouse monoclonal antibodies to focus human T cells against selected targets. J Exp Med (1988) 1.25
Motility and substratum adhesion of Dictyostelium wild-type and cytoskeletal mutant cells: a study by RICM/bright-field double-view image analysis. J Cell Sci (1995) 1.23
Microtubule-mediated centrosome motility and the positioning of cleavage furrows in multinucleate myosin II-null cells. J Cell Sci (1998) 1.22
Development of antibacterial agents of the nalidixic acid type. Prog Drug Res (1977) 1.21
Osteonecrosis after chemotherapy. Lancet (1978) 1.17
Three-dimensional patterns and redistribution of myosin II and actin in mitotic Dictyostelium cells. J Cell Biol (1997) 1.14
Assessing the role of the ASP56/CAP homologue of Dictyostelium discoideum and the requirements for subcellular localization. J Cell Sci (1999) 1.13
[Evidence for tumor immunity in human malignant melanoma]. Schweiz Med Wochenschr (1970) 1.13
Differential gamma-interferon response of human colon carcinoma cells: inhibition of proliferation and modulation of immunogenicity as independent effects of gamma-interferon on tumor cell growth. Cancer Res (1985) 1.11
Effect of cytokines and lipopolysaccharide on CD14 antigen expression in human monocytes and macrophages. J Cell Biochem (1991) 1.09
Dermatophilus congolensis chronic nodular disease in man. Pediatrics (1974) 1.08
Summary of FDA workshop on ischemia reperfusion injury in kidney transplantation. Am J Transplant (2013) 1.07
The IQGAP-related protein DGAP1 interacts with Rac and is involved in the modulation of the F-actin cytoskeleton and control of cell motility. J Cell Sci (1998) 1.05
RacF1, a novel member of the Rho protein family in Dictyostelium discoideum, associates transiently with cell contact areas, macropinosomes, and phagosomes. Mol Biol Cell (1999) 1.04
Human B cells express membrane-bound and soluble forms of the CD14 myeloid antigen. Mol Immunol (1991) 1.04
Vitamin A deficiency effect on retina: dependence on light. Science (1971) 1.01
Supraependymal cells of hypothalamic third ventricle: identification as resident phagocytes of the brain. Science (1975) 1.00
Impairment of isoproterenol, H2 histamine, and prostaglandin E1 response of human granulocytes after incubation in vitro with live influenza vaccines. Am Rev Respir Dis (1979) 1.00
Supraependymal macrophages of third ventricle of hamster: morphological, functional and histochemical characterization in situ and in culture. J Comp Neurol (1980) 0.96
Gene for non-specific X-linked mental retardation maps in the pericentromeric region. Am J Med Genet (1991) 0.96
The "active" rosette test in immunodeficiency diseases. Clin Immunol Immunopathol (1975) 0.96
Distribution and metabolism of hexadecylphosphocholine in mice. Lipids (1987) 0.94
Cardiac Na(+)-Ca2+ exchange system in giant membrane patches. Ann N Y Acad Sci (1991) 0.94
The in vivo role of annexin VII (synexin): characterization of an annexin VII-deficient Dictyostelium mutant indicates an involvement in Ca(2+)-regulated processes. J Cell Sci (1995) 0.91
Actin-associated proteins in motility and chemotaxis of Dictyostelium cells. Symp Soc Exp Biol (1993) 0.91
Aminoglutethimide-induced hematologic toxicity: worldwide experience. Cancer Treat Rep (1985) 0.91
CHRONOLOGIC ASSOCIATION OF POLIOMYELITIS AND COXSACKIE VIRUS INFECTIONS. Proc Natl Acad Sci U S A (1955) 0.90
Autologous marrow recovery following allogeneic marrow transplantation in a patient with severe aplastic anemia. Exp Hematol (1976) 0.89
Monoclonal antibody against a membrane antigen characterizing leukemic human B-lymphocytes. Cancer Res (1982) 0.87
Pharmacokinetics and immunomodulatory effects on monocytes during prolonged therapy with liposomal muramyltripeptide. Biotherapy (1993) 0.87
Laparoscopic cholecystectomy. Surg Endosc (2001) 0.87
Opioid and benzodiazepine withdrawal syndrome in adult burn patients. Am Surg (2000) 0.86
Double-blind randomised trial of the antiemetic efficacy and safety of ondansetron and metoclopramide in advanced breast cancer patients treated with epirubicin and cyclophosphamide. Eur J Cancer (1991) 0.86
Tumor necrosis factor (TNF) alpha: control of TNF-sensitivity and molecular mechanisms of TNF-mediated growth inhibition. Blut (1987) 0.86
Hyperprolactinemia is an indicator of progressive disease and poor prognosis in advanced breast cancer. Int J Cancer (1984) 0.86
Laparoscopic sigmoid resection for diverticular disease has no advantages over open approach: midterm results of a randomized controlled trial. Langenbecks Arch Surg (2011) 0.86
Small intestinal disease in T cell deficiency. J Pediatr (1974) 0.85
Pharmacokinetic and pharmacodynamic basis for the treatment of metastatic breast cancer with high-dose medroxyprogesterone acetate. Cancer (1984) 0.85
DNA aberrations in urinary bladder cancer detected by flow cytometry and FISH. Urol Res (1997) 0.85
[Contribution to the occurrence of forearm abnormalities]. Z Orthop Ihre Grenzgeb (1967) 0.85
Aminoglutethimide in the treatment of premenopausal patients with metastatic breast cancer. Eur J Cancer Clin Oncol (1986) 0.84
Macrophages of hypothalamic third ventricle. I. Functional characterization of supraependymal cells in situ. J Neuropathol Exp Neurol (1982) 0.84
The mixed lymphocyte tumor cell culture and the fluorescein diacetate cytotoxicity test. Two useful methods for the demonstration of cell mediated tumor specific immunity in man. Acta Haematol (1970) 0.84
Cell-mediated immunity against malignant melanoma in monozygous twins. Cancer Res (1970) 0.83
Functional relationship of macrophages and basophils to the thymus gland. Scand J Immunol (1979) 0.83
Discrimination of monoamine uptake by membranes of adrenal chromaffin granules. Br J Pharmacol (1975) 0.83
Evidence for tumor-specific immunity in human malignant melanoma. Eur J Cancer (1971) 0.83
Spontaneous and cationic lipid-mediated uptake of antisense oligonucleotides in human monocytes and lymphocytes. J Pharmacol Exp Ther (1998) 0.83
[Tumor patients and alternative medicine. Attempt at characterizing users of alternative treatment methods in oncology]. Dtsch Med Wochenschr (1989) 0.83
Image processing for combined bright-field and reflection interference contrast video microscopy. Comput Methods Programs Biomed (1997) 0.83
[The use of paramedical treatment methods by cancer patients. A inquiry on 101 ambulatory patients]. Dtsch Med Wochenschr (1986) 0.82
The pharmacokinetics of high-dose medroxyprogesterone acetate (MPA) in the therapy of advanced breast cancer. Cancer Chemother Pharmacol (1982) 0.82
Prevention of cytotoxic drug induced skin ulcers with dimethyl sulfoxide (DMSO) and alpha-tocopherole. Eur J Cancer Clin Oncol (1987) 0.82
[Determination of the carcinoembryonic antigen (CEA) for predicting the success of therapy in metastatic breast cancer]. Dtsch Med Wochenschr (1983) 0.82
[Who uses alternative therapy in cancer? A patient survey]. Schweiz Rundsch Med Prax (1989) 0.82
[Immunosuppression: a paraneoplastic syndrome]. Schweiz Med Wochenschr (1971) 0.81
Specific suppression of human tumor necrosis factor-alpha synthesis by antisense oligodeoxynucleotides. Antisense Nucleic Acid Drug Dev (1996) 0.81
[On the elimination of delta-4-androstene-3,17-dione and testosterone following administration of choriongonadotropin, FSH or testosterone in healthy males and patient with nasopharyngeal fibromas]. Endokrinologie (1965) 0.81
Pattern of endogenous lectins in a human epithelial tumor. Cancer Res (1985) 0.81
Characterisation of the barrier caused by luminally secreted gastro-intestinal proteolytic enzymes for two novel cystine-knot microproteins. Amino Acids (2007) 0.80
Dysautonomia in Guillain-Barré syndrome with dorsal root ganglioneuropathy, wallerian degeneration, and fatal myocarditis. Ann Neurol (1984) 0.80
Lipid peroxidation of rat liver microsomes membranes related to a protein deficiency and/or a PCB treatment. Food Addit Contam (1990) 0.80
[Hartmann's procedure indication in colorectal carcinoma]. Chirurg (2004) 0.80
[Blood-brain barrier and the penetration of cytostatic drugs]. Klin Wochenschr (1985) 0.80
Mitomycin-induced haemolysis and renal failure. Lancet (1980) 0.80
Suppressed colony formation of peripheral blood lymphocytes in a patient with somatostatinoma. Clin Immunol Immunopathol (1986) 0.80
The potent platelet inhibitory effects of S-nitrosated albumin coating of artificial surfaces. J Am Coll Cardiol (1999) 0.80
[Contribution to the occurrence of Köhler's disease]. Z Orthop Ihre Grenzgeb (1968) 0.80
[Studies on the hormonal situation in nasopharyngeal fibroma]. Arch Geschwulstforsch (1963) 0.80
Oxidative stress may contribute to the intestinal dysfunction of weanling rats fed a low protein diet. J Nutr (1993) 0.80
Intraperitoneal immunotherapy of human ovarian carcinoma with Corynebacterium parvum. Cancer Res (1983) 0.80
[Life-saving air supported avalanche mission at night in high alpine terrain]. Anaesthesist (2012) 0.79
Aminoglutethimide. Penetration of the blood brain barrier. Invest New Drugs (1986) 0.79
Changes in quality of life following cognitive-behavioral group therapy for panic disorder. Eur Psychiatry (2009) 0.79
Intra-arterial perfusion therapy with 5-fluorouracil in patients with metastatic colorectal carcinoma and intractable pelvic pain. Recent Results Cancer Res (1983) 0.79
Binding characteristics of three complement dependent assays for the detection of immune complexes in human serum. J Clin Lab Immunol (1985) 0.79
[Metastasizing adenocarcinoma from an unknown primary tumor]. Dtsch Med Wochenschr (1984) 0.79
Phase II study of aminoglutethimide and medroxyprogesterone acetate in the treatment of patients with advanced breast cancer. Cancer Res (1982) 0.79
[1st experiences with Adriamycin, a new cytotoxic antibiotic, in combination chemotherapy of malignant tumors]. Schweiz Med Wochenschr (1972) 0.78
In vitro effects of antitumor antibody--chemotactic factor complexes. Clin Immunol Immunopathol (1982) 0.78
Chromatofocusing combined with the ELISA technique. A sensitive method for the analysis of immune complexes. J Immunol Methods (1983) 0.78
[Hormonal and electron microscopic studies of nasopharyngeal fibromas]. Acta Otolaryngol (1971) 0.78
[Thrombocytosis in malignant tumors]. Schweiz Med Wochenschr (1973) 0.78